scholarly journals Therapeutic Effects of Sleeve Gastrectomy and Ileal Transposition on Type 2 Diabetes in a Non-Obese Rat Model by Regulating Blood Glucose and Reducing Ghrelin Levels

2019 ◽  
Vol 25 ◽  
pp. 3417-3424
Author(s):  
Hui Wang ◽  
Xinxin Fa ◽  
Wei Qu ◽  
Jindong Fu ◽  
Kaiyun Fan ◽  
...  
2016 ◽  
Vol 12 (3) ◽  
pp. 541-549 ◽  
Author(s):  
Alper Celik ◽  
Eylem Cagiltay ◽  
Surendra Ugale ◽  
Muharrem Asci ◽  
Bahri Onur Celik ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Xiaofei Huang ◽  
Pan Weng ◽  
Huixin Zhang ◽  
Yingli Lu

Objective. As a complicated symbiotic system, intestinal flora is reported closely related to the development of type 2 diabetes recently. Sleeve gastrectomy is one of the approaches of bariatric surgery and could improve blood glucose control in type 2 diabetes patients. This study was to explore the relationship between remodeled intestinal flora and glucose metabolism in diabetic rats.Methods. 20 male diabetic rats were operated; 10 of them underwent sleeve gastrectomy, and 10 of them underwent sham operation. Meanwhile 10 male normal rats underwent sleeve gastrectomy as control. The animals’ weight and FBG had been measured. The composition changes of intestinal flora were detected by 16S rDNA sequence analysis.Results. In diabetic rats, weight and fasting blood glucose decreased significantly after sleeve gastrectomy. However, there was no significant change for weight and blood glucose in normal rats after operation. The intestinal flora of diabetic rats reduced in the proportion of Firmicutes and increased in the proportion of Bacteroidetes after sleeve gastrectomy.Conclusion. The change of dominant microorganisms in intestinal flora might play an important role in the glucose metabolism.


2012 ◽  
Vol 22 (12) ◽  
pp. 1865-1873 ◽  
Author(s):  
Dong Sun ◽  
Shaozhuang Liu ◽  
Guangyong Zhang ◽  
Weijie Chen ◽  
Zhibo Yan ◽  
...  

2017 ◽  
Vol 4 (S) ◽  
pp. 88
Author(s):  
Phuong Thi-Bich Le ◽  
Phuc Van Pham ◽  
Ngoc Bich Vu ◽  
Loan Thi-Tung Dang ◽  
Ngoc Kim Phan

Introduction: Type 2 diabetes mellitus (T2D) is the most common form of diabetes mellitus, accounting for 90% of diabetes mellitus in patients. At the present time, although T2D can be treated by various drugs and therapies using insulin replacement, reports have shown that complications including microvascular, macrovascular complications and therapy resistance can occur in patients on long term treatment. Stem cell therapy is regarded as a promising therapy for diabetes mellitus, including T2D. The aim of this study was to evaluate the safety and therapeutic effect of expanded autologous adipose derived stem cell (ADSC) transplantation for T2D treatment; the pilot study included 3 patients who were followed for 3 months. Methods: The ADSCs were isolated from stromal vascular fractions, harvested from the belly of the patient,and expanded for 21 days per previously published studies. Before transplantation, ADSCs were evaluated for endotoxin, mycoplasma contamination, and karyotype. All patients were transfused with ADSCs at 1-2x106 cells/kg of body weight.Patients were evaluated for criteria related to transplantation safety and therapeutic effects; these included fever, blood glucose level before transplantation of ADSCs, and blood glucose level after transplantation (at 1, 2 and 3 months). Results: The results showed that all samples of ADSCs exhibited the MSC phenotype with stable karyotype (2n=46), there was no contamination of mycoplasma, and endotoxin levels were low (<0.25 EU/mL). No adverse effects were detected after 3 months of transplantation. Decreases of blood glucose levels were recorded in all patients. Conclusion: The findings from this initial study show that expanded autologous ADSCs may be a promising treatment for T2D.


Chirurgia ◽  
2019 ◽  
Vol 114 (6) ◽  
pp. 732 ◽  
Author(s):  
Laurian Stoica ◽  
Amadeus Dobrescu ◽  
Alexandru Isaic ◽  
Gabriel Verdeş ◽  
Cristi Tarţa ◽  
...  

2016 ◽  
Vol 3 (12) ◽  
pp. 1034 ◽  
Author(s):  
Phuong Thi-Bich Le ◽  
Phuc Van Pham ◽  
Ngoc Bich Vu ◽  
Loan Thi-Tung Dang ◽  
Ngoc Kim Phan

Introduction: Type 2 diabetes mellitus (T2D) is the most common form of diabetes mellitus, accounting for 90% of diabetes mellitus in patients. At the present time, althoughT2D can be treated by various drugs and therapies using insulin replacement, reports have shown that complications including microvascular, macrovascular complications and therapy resistance can occur in patients on long term treatment. Stem cell therapy is regarded as a promising therapy for diabetes mellitus, including T2D. The aim of this study was to evaluate the safety and therapeutic effect of expanded autologous adipose derived stem cell (ADSC) transplantation for T2D treatment; the pilot study included 3 patients who were followed for 3 months. Methods: The ADSCs were isolated from stromal vascular fractions, harvested from the belly of the patient,and expanded for 21 days per previously published studies. Before transplantation, ADSCs were evaluated for endotoxin, mycoplasma contamination, and karyotype.All patients were transfused with ADSCs at 1-2x106 cells/kg of body weight.Patients were evaluated for criteria related to transplantation safety and therapeutic effects; these included fever, blood glucose level before transplantation of ADSCs, and blood glucose level after transplantation (at 1, 2 and 3 months).Results: The results showed that all samples of ADSCs exhibited the MSC phenotype with stable karyotype (2n=46), there was no contamination of mycoplasma, and endotoxin levels were low (0.25 EU/mL). No adverse effects were detected after 3 months of transplantation. Decreases of blood glucose levels were recorded in all patients. Conclusion: The findings from this initial study show that expanded autologous ADSCs may be a promising treatment for T2D.


2017 ◽  
Vol 2 (3) ◽  
pp. 258
Author(s):  
Andri Rudi Yanto ◽  
Nurul Mahmudati ◽  
Rr. Eko Susetyarini

Hiperglikemik merupakan salah satu gejala DM  yang ditandai dengan meningkatnya konsentrasi gula darah dan pengeluaran glukosa yang disertai dengan gangguan metabolisme karbohidrat, penyakit ini masih banyak di Indonesia. Obat antidiabetes kebanyakan dapat memberikan efek samping yang tidak diinginkan, maka banyak para ahli yang meramu pengobatan tradisional untuk DM yang memberikan efek aman. Penelitian ini bertujuan untuk mengungkap potensi keanekaragaman hayati rimpang jahe sebagai obat antidiabetes yang dalam bentuk seduhan  pada tikus yang diinduksi STZ. Jenis penelitian adalah True Experiment Design. Tikus dibagi menjadi 4 kelompok, yaitu kelompok normal, kelompok positif (STZ), kelompok STZ + seduhan jahe 1g/kgBB, dan kelompok STZ + seduhan jahe 3g/kgBB. Hasil penelitian menunjukkan ada pengaruh seduhan jahe sebagai obat antidiabetes pada tikus induksi STZ. Rerata kadar glukosa darah tertinggi pada kelompok positif (STZ) dan kadar glukosa darah terendah pada kelompok STZ + seduhan jahe 1g/kgBB. Penelitian ini dimanfaatkan sebagai sumber belajar berupa poster ilmiah sebagai bahan acuan untuk guru dalam pembelajaran biologi materi upaya keanekaragaman hayati dan pemanfaatannya.


2005 ◽  
Vol 15 (9) ◽  
pp. 1258-1264 ◽  
Author(s):  
Alberto Patriti ◽  
Enrico Facchiano ◽  
Claudia Annetti ◽  
Maria Cristina Aisa ◽  
Francesco Galli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document